MedTrace Logo

Using Infrared Spectroscopy to Analyze Volatile Organic Compounds (VOCs) in the Breath of Patients With Lung Cancer

NCT06288646 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2024-05-31

No results posted yet for this study

Summary

The goal of this clinical trial is to compare breath samples from patients with lung cancer, those with stable lung nodules, and individuals without lung cancer. The main questions it aims to answer are whether breath patterns are different in these groups and to see if breath patterns change after treatment in patients with lung cancer.

Participants will be asked to provide one breath sample, and two if they get treated. They will also be asked to fill out a questionnaire about their background and medical history.

Conditions

Sponsors & Collaborators

  • Vitalite Health Network

    collaborator UNKNOWN

  • Breathe BioMedical Inc

    lead INDUSTRY

Principal Investigators

  • Nada Hammami · Vitalite Health Network

  • Marcel Mallet, MD · Vitalite Health Network

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-24
Primary Completion
2024-04-16
Completion
2024-05-15

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06288646 on ClinicalTrials.gov